0001209191-19-061775.txt : 20191223
0001209191-19-061775.hdr.sgml : 20191223
20191223160954
ACCESSION NUMBER: 0001209191-19-061775
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191219
FILED AS OF DATE: 20191223
DATE AS OF CHANGE: 20191223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HULME ALLISON
CENTRAL INDEX KEY: 0001573886
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36054
FILM NUMBER: 191306105
MAIL ADDRESS:
STREET 1: C/O SOPHIRIS BIO INC., 1258 PROSPECT ST
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOPHIRIS BIO INC.
CENTRAL INDEX KEY: 0001563855
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1258 PROSPECT STREET
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-777-1760
MAIL ADDRESS:
STREET 1: 1258 PROSPECT STREET
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-19
0
0001563855
SOPHIRIS BIO INC.
SPHS
0001573886
HULME ALLISON
1258 PROSPECT STREET
LA JOLLA
CA
92037
1
1
0
0
Chief Operating Officer
Common Stock (Right to Buy)
0.36
2019-12-19
4
A
0
123000
0.00
A
2020-12-19
2029-12-18
Common Stock
123000
123000
D
33% of the shares subject to the option shall vest one year after the date of grant. The remainder shall vest monthly thereafter over the next two years until fully vested on December 19, 2022.
Peter Slover Attorney-In-Fact
2019-12-23